+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
Chairman and Managing Director, Sun Pharmaceuticals
Dilip Shanghvi's low-key management style has turned Sun Pharma, maker of generic and branded drugs, into one of the most profitable pharma companies in India. Sun's priorities include cardiology, neurology, and psychiatry drugs. Shanghvi pursued M&As at home and overseas at a time when Indian companies rarely went shopping. Having waged a two-year legal battle, he hopes to score a big win soon with Sun gaining control over generics drugmaker Taro Pharmaceuticals of Israel.